Morínigo Rosa, Moizé Violeta, Musri Melina, Lacy Antonio M, Navarro Salvador, Marín José Luís, Delgado Salvadora, Casamitjana Roser, Vidal Josep
Obesity Unit, Hospital Clínic Universitari, Villarroel 170, 08036 Barcelona, Spain.
J Clin Endocrinol Metab. 2006 May;91(5):1735-40. doi: 10.1210/jc.2005-0904. Epub 2006 Feb 14.
The mechanisms underlying weight loss after Roux-en-Y gastric bypass (RYGBP) are not well understood.
The objective of the study was to assess the changes in active glucagon-like peptide 1 (GLP-1) and total peptide YY (PYY) after RYGBP and examine their relationship with changes in hunger and satiety.
This was a prospective study on the changes in active GLP-1, PYY, hunger, and satiety in response to a standardized test meal in nine normal-glucose-tolerant obese subjects [body mass index (BMI) 47.4 +/- 6.1 kg/m(2)] before and 6 wk after RYGBP.
Before surgery, meal ingestion failed to stimulate GLP-1 and PYY secretion. Six weeks after surgery, despite subjects still being markedly obese (BMI 43.6 +/- 7.8 kg/m(2)), the area under the curve(0-120') of GLP-1 and of PYY in response to the standardized test meal were significantly elevated (P < 0.05 and P < 0.01, respectively). These hormonal responses were significantly larger (P < 0.01) than those observed in a group matched for the BMI attained 6 wk after surgery. The 2.9 +/- 1.2- and 1.6 +/- 1.9-fold increase, respectively, in the area under the curve(0-120') of GLP-1 and PYY were accompanied by a significant decrease in fasting (P < 0.05) and postprandial hunger (P = 0.05) and a significant increase in satiety (P < 0.05) after meal intake. Nevertheless, a significant correlation between changes in the hormonal and eating behavior parameters was not found.
Our data show that RYGBP is associated with an improvement in the active GLP-1 and total PYY response to a liquid-meal intake. Moreover, we provide circumstantial evidence for a potential role of these gastrointestinal hormones on the decreased appetite after RYGBP.
Roux-en-Y胃旁路术(RYGBP)后体重减轻的潜在机制尚未完全明确。
本研究旨在评估RYGBP术后活性胰高血糖素样肽1(GLP-1)和总肽YY(PYY)的变化,并探讨它们与饥饿感和饱腹感变化的关系。
这是一项前瞻性研究,观察9名糖耐量正常的肥胖受试者[体重指数(BMI)47.4±6.1kg/m²]在RYGBP术前及术后6周,对标准化测试餐的活性GLP-1、PYY、饥饿感和饱腹感的变化。
术前,进餐未能刺激GLP-1和PYY分泌。术后6周,尽管受试者仍明显肥胖(BMI 43.6±7.8kg/m²),但标准化测试餐后GLP-1和PYY的曲线下面积(0-120分钟)显著升高(分别为P<0.05和P<0.01)。这些激素反应显著大于术后6周达到相同BMI的匹配组(P<0.01)。GLP-1和PYY的曲线下面积(0-120分钟)分别增加2.9±1.2倍和1.6±1.9倍,同时空腹饥饿感(P<0.05)和餐后饥饿感(P=0.05)显著降低,进餐后排饱腹感显著增加(P<0.05)。然而,未发现激素和饮食行为参数变化之间存在显著相关性。
我们的数据表明,RYGBP与液体餐摄入后活性GLP-1和总PYY反应的改善有关。此外,我们提供了间接证据,证明这些胃肠激素在RYGBP术后食欲下降中可能发挥作用。